Ian Magrath

Ian Magrath , International Network for Cancer Treatment & Research, Belgium Paolo Boffetta , International Agency for Research on Cancer, Lyon, France Michael Potter , NIH, Bethesda, USA Harald Stein , University of Berlin, Germany Randy Gascoyne , British Columbia Cancer Agency, Canada Claire Dearden , Royal Marsden Hospital, Sutton, Surrey, UK Volker Diehl , University of K�ln, Germany Ama Rohatiner , St Bartholomew's Hospital, London, UK Kishor Bhatia , NIH, Bethesda, USA

Ian Magrath , International Network for Cancer Treatment & Research, Belgium Paolo Boffetta , International Agency for Research on Cancer, Lyon, France Michael Potter , NIH, Bethesda, USA Harald Stein , University of Berlin, Germany Randy Gascoyne , British Columbia Cancer Agency, Canada Claire Dearden , Royal Marsden Hospital, Sutton, Surrey, UK Volker Diehl , University of K�ln, Germany Ama Rohatiner , St Bartholomew's Hospital, London, UK Kishor Bhatia , NIH, Bethesda, USA See less